InMed Pharmaceuticals, Inc. (INM)
1.44
+0.11
(+8.27%)
USD |
NASDAQ |
Oct 23, 16:00
1.54
+0.10
(+6.94%)
After-Hours: 20:00
InMed Pharmaceuticals Market Cap : 7.689M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.689M |
| October 22, 2026 | 7.101M |
| October 21, 2026 | 7.262M |
| October 20, 2026 | 7.155M |
| October 19, 2026 | 7.290M |
| October 16, 2026 | 7.048M |
| October 15, 2026 | 7.101M |
| October 14, 2026 | 6.995M |
| October 13, 2026 | 7.101M |
| October 12, 2026 | 7.262M |
| October 09, 2026 | 7.262M |
| October 08, 2026 | 7.101M |
| October 07, 2026 | 7.101M |
| October 06, 2026 | 7.101M |
| October 05, 2026 | 7.101M |
| October 02, 2026 | 7.101M |
| October 01, 2026 | 7.208M |
| September 30, 2026 | 7.262M |
| September 29, 2026 | 7.342M |
| September 28, 2026 | 7.262M |
| September 25, 2026 | 7.368M |
| September 24, 2026 | 7.475M |
| September 23, 2026 | 7.368M |
| September 22, 2026 | 7.422M |
| September 21, 2026 | 7.368M |
| Date | Value |
|---|---|
| September 18, 2026 | 7.262M |
| September 17, 2026 | 7.422M |
| September 16, 2026 | 6.834M |
| September 15, 2026 | 6.834M |
| September 14, 2026 | 6.941M |
| September 11, 2026 | 6.888M |
| September 10, 2026 | 6.995M |
| September 09, 2026 | 6.995M |
| September 08, 2026 | 7.101M |
| September 04, 2026 | 4.574M |
| September 03, 2026 | 4.408M |
| September 02, 2026 | 4.474M |
| September 01, 2026 | 4.375M |
| August 31, 2026 | 4.474M |
| August 28, 2026 | 4.574M |
| August 27, 2026 | 4.739M |
| August 26, 2026 | 4.739M |
| August 25, 2026 | 4.772M |
| August 24, 2026 | 4.739M |
| August 21, 2026 | 4.839M |
| August 20, 2026 | 5.236M |
| August 19, 2026 | 5.269M |
| August 18, 2026 | 4.772M |
| August 17, 2026 | 4.839M |
| August 14, 2026 | 4.872M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NervGen Pharma Corp. | 152.17M |
| Milestone Pharmaceuticals, Inc. | 80.70M |
| Appili Therapeutics, Inc. | 0.9001M |
| Clearmind Medicine, Inc. | 12.59M |
| Lexaria Bioscience Corp. | 5.090M |
Market Cap Related Metrics
| PS Ratio | 3.030 |
| Price to Book Value | 7.152 |
| Price | 1.44 |
| Earnings Yield | -216.4% |